Sudeep Das is an Ophthalmology physician affiliated with Medical University of South Carolina. OpenAlex indexes 21 publications with 264 citations (h-index 6); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
169 Ashley Ave
Room 202 Main Hospital, Msc333
Charleston, SC 294258905
Telephone
843-792-4074Registry record last updated 20 Jun 2016.
Clinical trials
- Accelerated Fractionation Radiotherapy (AFRT) Versus Concurrent Chemoradiotherapy (Crt) In Locally Advanced Head And Neck Squamous Cell Carcinoma
Sponsor: All India Institute of Medical Sciences
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Tarsus Pharmaceuticals, Inc.Program year20252 payments
- RxSight IncProgram year20251 payment
- ABBVIE INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
73.4%Prostaglandin Analog39.7%Latanoprost80%Lumigan12%Travoprost8%Part D<11 patientsCarbonic Anhydrase Inhibitor15.8%Dorzolamide-Timolol78%Dorzolamide Hcl22%Part D<11 patients+ 3 more classes in this area
Cardiovascular
16.5%Beta blocker16.5%Timolol Maleate100%Part D≥27 patientsAnti-infectives
7.2%Macrolide3.8%Erythromycin100%Part D≥17 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor3.4%Valacyclovir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Case of Extracellular Signal-Regulated Kinase Inhibitor–Associated Retinopathy
JAMA Ophthalmology
2020 - Efficacy of selective laser trabeculoplasty following incisional glaucoma surgery
International Journal of Ophthalmology
2018 - Analysis of the Relative Efficacy of Micropulse Laser Trabeculoplasty and Selective Laser Trabeculoplasty
Investigative Ophthalmology & Visual Science
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Tanya Turan, MD
Medical University of South Carolina
Michael Zile, MD
Medical University of South Carolina
Don Rockey, MD
Medical University of South Carolina
William Creasman, MD
Medical University of South Carolina
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”